John W. Holaday

10.0k total citations · 1 hit paper
138 papers, 7.8k citations indexed

About

John W. Holaday is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, John W. Holaday has authored 138 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Cellular and Molecular Neuroscience, 61 papers in Molecular Biology and 43 papers in Physiology. Recurrent topics in John W. Holaday's work include Neuropeptides and Animal Physiology (72 papers), Receptor Mechanisms and Signaling (42 papers) and Pain Mechanisms and Treatments (30 papers). John W. Holaday is often cited by papers focused on Neuropeptides and Animal Physiology (72 papers), Receptor Mechanisms and Signaling (42 papers) and Pain Mechanisms and Treatments (30 papers). John W. Holaday collaborates with scholars based in United States, Japan and Sweden. John W. Holaday's co-authors include Alan I. Faden, Edward W. Bernton, Joseph B. Long, Thomas P. Jacobs, Frank C. Tortella, Gregory Belenky, Henry G. Fein, Judith E. Beach, Robert C. Smallridge and Robert M. Rose and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

John W. Holaday

137 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Release of Multiple Hormones by a Direct Action of Interleukin-1 on Pituitary Cells

1987 542 citations Edward W. Bernton, Judith E. Beach et al. profile →

Peers

Countries citing papers authored by John W. Holaday

Since Specialization

Citations

This map shows the geographic impact of John W. Holaday's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John W. Holaday with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John W. Holaday more than expected).

Fields of papers citing papers by John W. Holaday

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John W. Holaday. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John W. Holaday. The network helps show where John W. Holaday may publish in the future.

Co-authorship network of co-authors of John W. Holaday

This figure shows the co-authorship network connecting the top 25 collaborators of John W. Holaday. A scholar is included among the top collaborators of John W. Holaday based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John W. Holaday. John W. Holaday is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antiangiogenic Activity of Prostate-Specific Antigen 1999 ·JNCI Journal of the National Cancer Institute ·A H Fortier, Barbara J. Nelson, Davida K. Grella, John W. Holaday	176
2	Prolactin and prolactin secretagogues reverse immunosuppression in mice treated with cysteamine, glucocorticoids, or cyclosporin-A 1992 ·Brain Behavior and Immunity ·Edward W. Bernton, Henry U. Bryant, John W. Holaday, Jitendra R. Dave	32
3	Upregulation of the opioid receptor complex by the chronic administration of morphine: A biochemical marker related to the development of tolerance and dependence 1991 ·Peptides ·Richard B. Rothman, Joseph B. Long, Victor Bykov, H. Y. Xu, Arthur E. Jacobson, Kenner C. Rice, John W. Holaday	54
4	Interaction of β‐funaltrexamine with [³H]cycloFOXY binding in rat brain: Further evidence that β‐FNA alkylates the opioid receptor complex 1991 ·Synapse ·(unknown), Victor Bykov, Artin Mahboubi, Joseph B. Long, Qi Jiang, Frank Porreca, B. R. DE COSTA, (unknown), Kenner C. Rice, John W. Holaday	22
5	Pretreatment of rats with the irreversible μ-receptor antagonist, β-FNA, fails to prevent naltrexone-induced upregulation of μ-opioid receptors 1990 ·Neuropharmacology ·Richard B. Rothman, Joseph B. Long, Victor Bykov, Arthur E. Jacobson, K.C. Rice, John W. Holaday	9
6	Effects of NMDA receptor antagonists following spinal ischemia in the rabbit 1990 ·Experimental Neurology ·Alberto Martinez‐Arizala, (unknown), Joseph B. Long, Joyce Kraimer, John W. Holaday	37
7	Rapid release of multiple hormones from rat pituitaries perifused with recombinant interleukin-1 1989 ·Life Sciences ·Judith E. Beach, Robert C. Smallridge, (unknown), Edward W. Bernton, John W. Holaday, Henry G. Fein	78
8	Arginine8-vasopressin reduces spinal cord blood flow after spinal subarachnoid injection in rats. 1989 ·Journal of Pharmacology and Experimental Therapeutics ·Joseph B. Long, Alberto Martinez‐Arizala, (unknown), John W. Holaday	6
9	Intravenous beta-endorphin: Behavioral and physiological effects in conscious monkeys 1989 ·Peptides ·Bruce N. Cuthbert, John W. Holaday, James L. Meyerhoff, Choh Hao Li	7
10	Effects of TRH in Circulatory Shock and Central Nervous System Ischemia 1989 ·Annals of the New York Academy of Sciences ·John W. Holaday, Joseph B. Long, Alberto Martinez‐Arizala, (unknown), David G. Reynolds, Nelson J. Gurll	6
11	The therapeutic efficacy of opiate antagonists in hemorrhagic shock 1989 ·Resuscitation ·David G. Reynolds, Nelson J. Gurll, John W. Holaday, (unknown)	15
12	Respiratory and cardiovascular effects of thyrotropin-releasing hormone as modified by isoflurane, enflurane, pentobarbital and ketamine 1989 ·Regulatory Peptides ·Carl F. Schaefer, Daniel J. Brackett, Björn Biber, Megan R. Lerner, John W. Holaday, Michael F. Wilson, Lennart Fagraeus	13
13	Chronic administration of morphine and naltrexone up-regulate μ-opioid binding sites labeled by [3H][D-Ala2, MePhe4, Gly-ol5]enkephalin: further evidence for two μ-binding sites 1989 ·European Journal of Pharmacology ·Richard B. Rothman, Victor Bykov, Joseph B. Long, Linda S. Brady, Arthur E. Jacobson, Kenner C. Rice, John W. Holaday	76
14	Hindlimb paralytic effects of prodynorphin-derived peptides following spinal subarachnoid injection in rats 1988 ·European Journal of Pharmacology ·Joseph B. Long, Alberto Martinez‐Arizala, (unknown), (unknown), John W. Holaday	21
15	Hindlimb paralytic effects of arginine vasopressin and related peptides following spinal subarachnoid injection in the rat 1988 ·Peptides ·Joseph B. Long, Alberto Martinez‐Arizala, (unknown), John W. Holaday	6
16	Chronic morphine upregulates a μ-opiate binding site labeled by [3H]cycloFOXY: a novel opiate antagonist suitable for positron emission tomography 1987 ·European Journal of Pharmacology ·Richard B. Rothman, Stafford McLean, Victor Bykov, Ralph A. Lessor, Arthur E. Jacobson, Kenner C. Rice, John W. Holaday	29
17	Glucagon's chronotropic action is calcium dependent. 1987 ·Journal of Pharmacology and Experimental Therapeutics ·B Chernow, (unknown), Diana Malcolm, Shawna C. Willey, Margie L. Clapper, John W. Holaday	19
18	Endogenous Opioids in Spinal Cord Injury: A Critical Evaluation 1986 ·PubMed ·Joseph B. Long, Alberto Martinez‐Arizala, J.M. Petras, John W. Holaday	17
19	Naloxone treatment of endotoxin shock: stereospecificity of physiologic and pharmacologic effects in the rat. 1980 ·Journal of Pharmacology and Experimental Therapeutics ·Alan I. Faden, John W. Holaday	106
20	Adrenal steroids indirectly modulate morphine and beta-endorphin effects. 1979 ·Journal of Pharmacology and Experimental Therapeutics ·John W. Holaday, Ping‐Yee Law, Hwei‐San Loh, C H Li	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact